OSE Immunotherapeutics SA (ORPOF) Price
ORPOF Stock Price Chart
ORPOF Financial
OSE Immunotherapeutics SA
$0
0%
$0
$0
0%
$0
Income
Balance sheet
Cash flow
Annual
Quarterly
ORPOF Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|
| Revenue | 2 | 83 | 2 | 18 | 26 | 10 |
| Revenue Growth (YoY) | -98% | 4,050% | -89% | -31% | 160% | -60% |
| Cost of Revenue | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | 10 | 9 | 7 | 8 | 11 | 6 |
| Research & Development | 33 | 32 | 24 | 29 | 33 | 27 |
| Operating Expenses | 37 | 39 | 25 | 36 | 42 | 29 |
| Other Non Operating Income (Expenses) | 0 | 1 | 0 | 0 | 0 | 0 |
| Pretax Income | -35 | 39 | -23 | -18 | -17 | -19 |
| Income Tax Expense | -1 | 2 | 0 | 0 | 0 | -2 |
| Net Income | -34 | 37 | -23 | -17 | -16 | -16 |
| Net Income Growth | -174% | -261% | 35% | 6% | 0% | 300% |
| Shares Outstanding (Diluted) | 22.11 | 21.89 | 19.56 | 18.52 | 18.15 | 15.55 |
| Shares Change (YoY) | -12% | 12% | 6% | 2% | 17% | 4% |
| EPS (Diluted) | -1.58 | 1.71 | -1.17 | -0.95 | -0.92 | -1.06 |
| EPS Growth | -187% | -245% | 23% | 3% | -13% | 241% |
| Free Cash Flow | -37 | 48 | -19 | -18 | -10 | -19 |
| Free Cash Flow Per Share | -1.67 | 2.19 | -0.97 | -0.97 | -0.55 | -1.22 |
| Gross Margin | -- | -- | -- | -- | -- | -- |
| Operating Margin | -1,750% | 51.8% | -1,150% | -100% | -61.53% | -180% |
| Profit Margin | -1,700% | 44.57% | -1,150% | -94.44% | -61.53% | -160% |
| Free Cash Flow Margin | -1,850% | 57.83% | -950% | -100% | -38.46% | -190% |
| EBITDA | -32 | 46 | -20 | -15 | -14 | -18 |
| EBITDA Margin | -1,600% | 55.42% | -1,000% | -83.33% | -53.84% | -180% |
| D&A For EBITDA | 3 | 3 | 3 | 3 | 2 | 0 |
| EBIT | -35 | 43 | -23 | -18 | -16 | -18 |
| EBIT Margin | -1,750% | 51.8% | -1,150% | -100% | -61.53% | -180% |
| Effective Tax Rate | 2.85% | 5.12% | 0% | 0% | 0% | 10.52% |
Follow-Up Questions
¿Cuáles son los estados financieros clave de OSE Immunotherapeutics SA?
¿Cuáles son los ratios financieros clave para ORPOF?
¿Cómo se desglosan los ingresos de OSE Immunotherapeutics SA por segmento o geografía?
¿Es rentable OSE Immunotherapeutics SA?
¿Tiene OSE Immunotherapeutics SA alguna deuda?
¿Cuántas acciones en circulación tiene OSE Immunotherapeutics SA?
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About ORPOF